Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.4K
Overview
45.4K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

5.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.3K
Active versus Passive Immunity01:31

Active versus Passive Immunity

4.6K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The dynamics of COVID-19 spread: evidence from Lebanon.

Mathematical biosciences and engineering : MBE·2020
Same author

Awareness and intake of folic acid for the prevention of neural tube defects among Lebanese women of childbearing age.

Maternal and child health journal·2011
See all related articles

Related Experiment Video

Updated: Sep 23, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K

Efficacy versus abundancy: Comparing vaccination schemes.

Omar El Deeb1,2, Maya Jalloul3

  • 1Department of Natural Sciences, Lebanese American University, Beirut, Lebanon.

Plos One
|May 13, 2022
PubMed
Summary

Higher vaccination rates with lower efficacy vaccines can reduce deaths more effectively than slower deployment of high efficacy vaccines. Early, rapid, lower-efficacy vaccination is key for reducing mortality.

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.4K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.3K

Related Experiment Videos

Last Updated: Sep 23, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.4K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.3K

Area of Science:

  • Epidemiology
  • Mathematical Modeling
  • Public Health

Background:

  • Vaccine deployment strategies significantly impact disease control outcomes.
  • Understanding the interplay between vaccine efficacy, deployment speed, and timing is crucial for pandemic response.

Purpose of the Study:

  • To develop and analyze a novel compartmental model for vaccine deployment.
  • To compare the impact of different vaccine efficacies, deployment rates, and timings on disease mortality and infection rates.

Main Methods:

  • A novel compartmental model was developed to simulate disease spread under various vaccination scenarios.
  • Simulations explored different vaccine efficacies, deployment rates, and initiation timings.
  • Model outputs were analyzed to quantify cumulative deaths, infections, and herd immunity.

Main Results:

  • Higher abundance and faster deployment rates of low efficacy vaccines led to fewer cumulative deaths compared to slower deployment of high efficacy vaccines.
  • Earlier introduction of vaccination schemes, even with lower efficacy, reduced deaths more than delayed introduction of high efficacy vaccines.
  • High efficacy vaccines, despite slower deployment, could achieve lower infection numbers and better herd immunity.

Conclusions:

  • Rapid deployment of even low efficacy vaccines can be a superior strategy for minimizing mortality during an outbreak.
  • Vaccine timing and deployment rate are critical factors, potentially outweighing efficacy in reducing overall deaths.
  • A balanced approach considering both rapid deployment and vaccine efficacy is necessary for comprehensive pandemic control.